受强制性开放获取政策约束的文章 - Elizabeth Ahern了解详情
可在其他位置公开访问的文章：12 篇
CD155 on tumor cells drives resistance to immunotherapy by inducing the degradation of the activating receptor CD226 in CD8+ T cells
M Braun, AR Aguilera, A Sundarrajan, D Corvino, K Stannard, S Krumeich, ...
Immunity 53 (4), 805-823. e15, 2020
强制性开放获取政策： Swiss National Science Foundation, National Health and Medical Research …
Roles of the RANKL–RANK axis in antitumour immunity—implications for therapy
E Ahern, MJ Smyth, WC Dougall, MWL Teng
Nature reviews Clinical oncology 15 (11), 676-693, 2018
强制性开放获取政策： National Health and Medical Research Council, Australia
RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer
E Ahern, H Harjunpää, JS O'Donnell, S Allen, WC Dougall, MWL Teng, ...
Oncoimmunology 7 (6), e1431088, 2018
强制性开放获取政策： National Health and Medical Research Council, Australia
Targeting adenosine in BRAF-mutant melanoma reduces tumor growth and metastasis
A Young, SF Ngiow, J Madore, J Reinhardt, J Landsberg, A Chitsazan, ...
Cancer Research 77 (17), 4684-4696, 2017
强制性开放获取政策： National Health and Medical Research Council, Australia, European Commission
Co-administration of RANKL and CTLA4 antibodies enhances lymphocyte-mediated antitumor immunity in mice
E Ahern, H Harjunpää, D Barkauskas, S Allen, K Takeda, H Yagita, ...
Clinical Cancer Research 23 (19), 5789-5801, 2017
强制性开放获取政策： National Health and Medical Research Council, Australia
Tumor CD155 expression is associated with resistance to anti-PD1 immunotherapy in metastatic melanoma
A Lepletier, J Madore, JS O'Donnell, RL Johnston, XY Li, E McDonald, ...
Clinical cancer research 26 (14), 3671-3681, 2020
强制性开放获取政策： National Health and Medical Research Council, Australia
An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancer.
A Liede, RK Hernandez, SW Wade, R Bo, E Ahern, WC Dougall, ...
Journal of Clinical Oncology 36 (15_suppl), e21001-e21001, 2018
强制性开放获取政策： National Health and Medical Research Council, Australia
Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis
H Harjunpää, SJ Blake, E Ahern, S Allen, J Liu, J Yan, V Lutzky, K Takeda, ...
Oncoimmunology 7 (7), e1445949, 2018
强制性开放获取政策： National Health and Medical Research Council, Australia
Profiling vaccine believers and skeptics in nurses: A latent profile analysis
CLK Leung, KK Li, VWI Wei, A Tang, SYS Wong, SS Lee, KO Kwok
International journal of nursing studies 126, 104142, 2022
强制性开放获取政策： Wellcome Trust
Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication
WJ Tu, RD McCuaig, M Melino, DJ Rawle, TT Le, K Yan, A Suhrbier, ...
Cell Discovery 7 (1), 37, 2021
强制性开放获取政策： National Health and Medical Research Council, Australia
Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8+ T Cells in …
J Dunn, RD McCuaig, AHY Tan, WJ Tu, F Wu, KM Wagstaff, A Zafar, S Ali, ...
Cancers 14 (6), 1596, 2022
强制性开放获取政策： National Health and Medical Research Council, Australia
Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological …
A Body, E Ahern, L Lal, K Gillett, H Abdulla, S Opat, T O’Brien, P Downie, ...
BMC infectious diseases 22 (1), 70, 2022
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定